A double-blind, placebo-controlled, randomized withdrawal study of lurasidone for the maintenance of efficacy in patients with schizophrenia

  • computer science
  • text mining

This paper was published in Crossref.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.